Ontology highlight
ABSTRACT:
SUBMITTER: Zamani F
PROVIDER: S-EPMC4708029 | biostudies-other | 2015 Dec
REPOSITORIES: biostudies-other
Zamani Fatemeh F Almasi Shohreh S Kazemi Tohid T Jahanban Esfahlan Rana R Aliparasti Mohammad Reza MR
Advanced pharmaceutical bulletin 20151231 Suppl 1
Type 1 diabetes (T1D) is a pancreatic beta cell specific autoimmune disease. One of the most significant current discussions in T1D studies is therapy. Since the conventional therapy, islet transplantation and external insulin, e.g., cannot prevent the destructive autoimmune process against original beta cells and persistent hyperglycemia remains, so recent developments in the field of T1D therapy paved the way to a renewed interest in immunotherapy based on the disease process, especially monoc ...[more]